Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2025.
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rossari Biotech has filed a routine quarterly compliance certificate under SEBI's Depositories Regulations for the fourth quarter of FY25 (January–March 2025). This certificate is submitted by the company's Registrar and Transfer Agent (RTA) to confirm that all shares held in dematerialized (demat) form have been properly processed and reconciled with the depositories. The filing is a standard regulatory requirement and does not involve any change in shareholding, capital structure, or business operations. No specific numbers, transactions, or material details are disclosed in this filing.
This is a procedural compliance filing with no material impact on the company's financials, operations, or shareholders. Investors can safely treat it as routine housekeeping required by SEBI rules.